Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Glioblastoma 31Gliosarcoma 27Astrocytoma 22Brain Neoplasms 17Central Nervous System Neoplasms 16Oligodendroglioma 12Medulloblastoma 9Neuroblastoma 7Glioma 7Choroid Plexus Neoplasms 7Sarcoma 6Melanoma 6Familial ependymoma 6Optic Nerve Glioma 5Spinal Cord Neoplasms 4Rhabdoid Tumor 4Neuroectodermal Tumors, Primitive, Peripheral 4Ependymoma 4Uveal Melanoma 3Rhabdomyosarcoma 3Ovarian Neoplasms 3Osteosarcoma 3Neuroectodermal Tumors, Primitive 3Breast Neoplasms 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Small Cell Lung Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pinealoma 2

Interventions

Cytarabine 33Etoposide 16Daunorubicin 16tipifarnib 10Mitoxantrone 10Idarubicin 9Azacitidine 8alvocidib 6Filgrastim 6Busulfan 6Peripheral Blood Stem Cell Transplantation 5valspodar 4Sorafenib 4Bortezomib 4fludarabine phosphate 3entinostat 3aldesleukin 3Vorinostat 3Tretinoin 3Radiotherapy 3Lenalidomide 3Gemtuzumab 3Decitabine 3Cyclophosphamide 3veliparib 2tanespimycin 2sargramostim 2lintuzumab 2laromustine 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Myelomonocytic, Acute × Temozolomide × Clear all
NCT01139970 2025-11-20

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
66 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡